Another important paper was published by independent researchers confirming Dr. Goodenowe’s (Founder and CEO, Prodrome Sciences) original discovery and hypothesis that plasmalogen deficiency is the key underlying causative factor in Alzheimer’s. In this new paper, researchers did a comprehensive comparison of blood biomarkers of Alzheimer’s in two large clinical trials – one from the USA and one from Australia. The results unambiguously reveal that not only are all classes of plasmalogen phospholipids deficient in persons with Alzheimer’s, but that alkyl-acyl glycerols (the biochemical precursors of plasmalogens) are the most depleted.
Prodrome Sciences’ alkyl-acyl glycerol plasmalogen supplements are the only proven bioavailable plasmalogen supplements available that are confirmed to replenish plasmalogen levels in the body. Plasmalogen levels can be checked with the ProdromeScan blood test before and after supplementation.